{
    "Trade/Device Name(s)": [
        "IMMULITE\u00ae 2000 Anti-TG Ab Calibration Verification Material",
        "IMMULITE\u00ae 2000 Anti-TPO Ab Calibration Verification Material",
        "IMMULITE\u00ae 2000 Thyroglobulin Calibration Verification Material"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics Inc.",
    "510(k) Number": "K132391",
    "Predicate Device Reference 510(k) Number(s)": [
        "K020369",
        "K001014",
        "K020217"
    ],
    "Regulatory Class": "Class I Reserved",
    "Product Code(s)": [
        "JJX"
    ],
    "Summary Letter Date": "July 31, 2013",
    "Summary Letter Received Date": "August 1, 2013",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Quality control material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "endocrine",
        "chemistry"
    ],
    "Analyte(s)": [
        "Anti-TG Ab",
        "Anti-TPO Ab",
        "Thyroglobulin"
    ],
    "Specimen Type(s)": [
        "Human serum",
        "Horse serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "IMMULITE\u00ae 2000 Systems"
    ],
    "Method(s)/Technology(ies)": [
        "Calibration verification material",
        "Lyophilized control material"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Calibration Verification Material",
        "Quality Control Material"
    ],
    "Document Summary": "FDA 510(k) summary for IMMULITE 2000 Calibration Verification Materials for Anti-TG Ab, Anti-TPO Ab, and Thyroglobulin assays as quality control materials for IMMULITE 2000 systems.",
    "Indications for Use Summary": "For in vitro diagnostic use in verification of calibration of IMMULITE Anti-TG Ab, Anti-TPO Ab, and Thyroglobulin assays on IMMULITE 2000 systems as indicated in the CVM Package Insert.",
    "fda_folder": "Clinical Chemistry"
}